Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NATHAN STRANDMARK

Allopathic & Osteopathic Physicians Family Medicine

NPI
1457428518
CMS profile
202300
Location
GARDEN CITY, KS

General Payments · PY2018–2024

$2,398.00

  • Reported across 149 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$657.64

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $657.64 38

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $37.93 3
PY2019 $21.51 1
PY2021 $257.44 17
PY2022 $914.07 55
PY2023 $509.41 35
PY2024 $657.64 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ALK-Abello, Inc $16.25 05/08/2024 Food and Beverage Undisputed 01/23/2026 1099895683 CMS
Amgen Inc. $16.99 01/16/2024 Food and Beverage Undisputed 01/23/2026 1117694186 CMS
Amgen Inc. $16.26 03/26/2024 Food and Beverage Undisputed 01/23/2026 1117694188 CMS
Antares Pharma, Inc. $14.92 08/20/2024 Food and Beverage Undisputed 01/23/2026 1146488286 CMS
AstraZeneca Pharmaceuticals LP $63.92 01/26/2024 Food and Beverage Undisputed 01/23/2026 1105659514 CMS
AstraZeneca Pharmaceuticals LP $11.60 03/06/2024 Food and Beverage Undisputed 01/23/2026 1105545001 CMS
AstraZeneca Pharmaceuticals LP $16.03 05/13/2024 Food and Beverage Undisputed 01/23/2026 1105590880 CMS
AstraZeneca Pharmaceuticals LP $13.48 06/26/2024 Food and Beverage Undisputed 01/23/2026 1105668891 CMS
AstraZeneca Pharmaceuticals LP $17.17 07/23/2024 Food and Beverage Undisputed 01/23/2026 1105638450 CMS
AstraZeneca Pharmaceuticals LP $16.73 09/23/2024 Food and Beverage Undisputed 01/23/2026 1105499700 CMS
Axsome Therapeutics, Inc. $16.65 02/08/2024 Food and Beverage Undisputed 01/23/2026 1148307992 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.27 05/29/2024 Food and Beverage Undisputed 01/23/2026 1086113948 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.38 03/06/2024 Food and Beverage Undisputed 01/23/2026 1118016734 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.64 10/15/2024 Food and Beverage Undisputed 01/23/2026 1118016736 CMS
CeQur Corporation $16.99 11/06/2024 Food and Beverage Undisputed 01/23/2026 1126845582 CMS
Dexcom, Inc. $24.31 09/18/2024 Food and Beverage Undisputed 01/23/2026 1153324975 CMS
Exact Sciences Corporation $17.07 04/29/2024 Food and Beverage Undisputed 01/23/2026 1114920562 CMS
Exact Sciences Corporation $13.86 11/13/2024 Food and Beverage Undisputed 01/23/2026 1114920569 CMS
Genentech USA, Inc. $23.40 10/17/2024 Food and Beverage Undisputed 01/23/2026 1133078944 CMS
Greer Laboratories, Inc. $13.45 04/10/2024 Food and Beverage Undisputed 01/23/2026 1131113839 CMS
Greer Laboratories, Inc. $15.67 04/12/2024 Food and Beverage Undisputed 01/23/2026 1131113845 CMS
Lilly USA, LLC $19.65 03/01/2024 Food and Beverage Undisputed 01/23/2026 1135283236 CMS
Medtronic, Inc. $13.59 03/27/2024 Food and Beverage Undisputed 01/23/2026 1119326369 CMS
Merck Sharp & Dohme LLC $18.92 08/13/2024 Food and Beverage Undisputed 01/23/2026 1141952891 CMS
Novartis Pharmaceuticals Corporation $18.00 03/13/2024 Food and Beverage Undisputed 01/23/2026 1087235309 CMS
Novo Nordisk Inc $17.00 01/02/2024 Food and Beverage Undisputed 01/23/2026 1097452521 CMS
Novo Nordisk Inc $14.06 01/19/2024 Food and Beverage Undisputed 01/23/2026 1097710625 CMS
Novo Nordisk Inc $17.64 02/02/2024 Food and Beverage Undisputed 01/23/2026 1096601551 CMS
Novo Nordisk Inc $10.42 02/27/2024 Food and Beverage Undisputed 01/23/2026 1097383417 CMS
Novo Nordisk Inc $16.19 04/03/2024 Food and Beverage Undisputed 01/23/2026 1096581239 CMS
Novo Nordisk Inc $13.21 05/02/2024 Food and Beverage Undisputed 01/23/2026 1097380190 CMS
Novo Nordisk Inc $14.79 06/24/2024 Food and Beverage Undisputed 01/23/2026 1096935931 CMS
Novo Nordisk Inc $15.97 08/13/2024 Food and Beverage Undisputed 01/23/2026 1096879545 CMS
Novo Nordisk Inc $13.68 10/09/2024 Food and Beverage Undisputed 01/23/2026 1096629921 CMS
Novo Nordisk Inc $16.16 10/18/2024 Food and Beverage Undisputed 01/23/2026 1097375344 CMS
Novo Nordisk Inc $13.02 12/06/2024 Food and Beverage Undisputed 01/23/2026 1096690031 CMS
PFIZER INC. $13.37 10/08/2024 Food and Beverage Undisputed 01/23/2026 1132082494 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.93 12/23/2024 Food and Beverage Undisputed 01/23/2026 1153461896 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.